RISPERIDONE ASCENT risperidone 4mg film-coated tablet blister pack

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

risperidone, Quantity: 4 mg

Disponible desde:

Medis Pharma Pty Ltd

Designación común internacional (DCI):

Risperidone

formulario farmacéutico:

Tablet, film coated

Composición:

Excipient Ingredients: colloidal anhydrous silica; maize starch; indigo carmine; hypromellose; magnesium stearate; quinoline yellow; microcrystalline cellulose; lactose monohydrate; titanium dioxide; macrogol 400

Vía de administración:

Oral

Unidades en paquete:

60 tablets

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Risperidone Ascent is indicated for the treatment of schizophrenia and related psychoses. Risperidone Ascent is indicated for the treatment of behavioural disturbances in dementia. Risperidone Ascent is indicated for the treatment of conduct and other disruptive disorders in children (over 5 years), adolescents and adults with sub average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent. (See Clinical Trials for maintenance data).

Resumen del producto:

Visual Identification: Green, film-coated, oblong tablet engraved with "R", a breakline and "4" on one side and a plain face on the other.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 4 Years; Container Temperature: Store below 25 degrees Celsius

Estado de Autorización:

Licence status A

Fecha de autorización:

2012-09-26